ALDX FY 2021 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$318M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$56M

Net Income

-$58M

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$233M

Total Liabilities

$27M

Stockholders' Equity

$206M

Cash & Equivalents

$230M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$56,221	+100.0%
Operating Income	-$56M	-$35M	-62.2%
Net Income	-$58M	-$38M	-53.8%